Get the Stockscreener App
12.08
0.00%
0.00
Cogent Biosciences Inc stock is traded at $12.08, with a volume of 1.06M.
It is up +0.00% in the last 24 hours and up +2.03% over the past month.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
See More
Previous Close:
$12.08
Open:
$12.08
24h Volume:
1.06M
Relative Volume:
0.39
Market Cap:
$1.38B
Revenue:
-
Net Income/Loss:
$-284.08M
P/E Ratio:
-6.7865
EPS:
-1.78
Net Cash Flow:
$-234.65M
1W Performance:
-0.33%
1M Performance:
+2.03%
6M Performance:
+72.82%
1Y Performance:
+17.51%
1-Day Range:
$11.88
$12.21
1-Week Range:
$11.77
$12.84
52-Week Range:
$3.72
$12.97
Cogent Biosciences Inc Stock (COGT) Company Profile
Name
Cogent Biosciences Inc
Sector
Industry
Phone
617-945-5576
Address
275 WYMAN STREET, WALTHAM
Compare COGT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
12.08 | 1.69B | 0 | -284.08M | -234.65M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Dec-11-24 | Downgrade | Needham | Buy → Hold |
| Feb-26-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-08-24 | Initiated | Citigroup | Buy |
| Dec-11-23 | Downgrade | Wedbush | Outperform → Neutral |
| Dec-08-23 | Initiated | JP Morgan | Overweight |
| Apr-28-23 | Initiated | Robert W. Baird | Outperform |
| Mar-27-23 | Resumed | H.C. Wainwright | Buy |
| Dec-14-22 | Initiated | Needham | Buy |
| Jun-28-22 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | H.C. Wainwright | Buy |
| Jun-09-21 | Resumed | Jefferies | Buy |
| Dec-23-20 | Initiated | Piper Sandler | Overweight |
| Oct-14-20 | Initiated | Ladenburg Thalmann | Buy |
View All
Cogent Biosciences Inc Stock (COGT) Latest News
Is Cogent Biosciences Inc. still worth holding after the dip2025 Market Trends & Low Drawdown Investment Ideas - Newser
Using data filters to optimize entry into Cogent Biosciences Inc.2025 Institutional Moves & Verified Entry Point Signals - Newser
What’s the recovery path for long term holders of Cogent Biosciences Inc.2025 Risk Factors & AI Based Buy and Sell Signals - Newser
Signal strength of Cogent Biosciences Inc. stock in tech scannersWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - Newser
How sentiment analysis helps forecast Cogent Biosciences Inc.2025 Key Highlights & Technical Pattern Alert System - Newser
Is it too late to sell Cogent Biosciences Inc.Earnings Risk Summary & Smart Swing Trading Alerts - Newser
Automated trading signals detected on Cogent Biosciences Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Cogent Biosciences Inc. stock daily chart insightsPortfolio Update Summary & Risk Managed Trade Strategies - Newser
Cogent Biosciences Inc. Stock Flags Risk Zone in Volatility IndexEarnings Miss & Intraday High Probability Setup Alerts - beatles.ru
Technical analysis overview for Cogent Biosciences Inc. stockJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Real time alert setup for Cogent Biosciences Inc. performance2025 Top Decliners & Free Low Drawdown Momentum Trade Ideas - Newser
Reversal Traders Monitor Cogent Biosciences Inc. for Entry getLinesFromResByArray error: size == 0 - thegnnews.com
How to use a screener to detect Cogent Biosciences Inc. breakoutsPortfolio Growth Summary & AI Driven Stock Reports - Newser
What to expect from Cogent Biosciences Inc. in the next 30 daysWeekly Investment Report & Fast Entry Momentum Alerts - Newser
Analyzing recovery setups for Cogent Biosciences Inc. investors2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
Using economic indicators to assess Cogent Biosciences Inc. potentialEarnings Risk Report & Long-Term Investment Growth Plans - Newser
Should you hold or exit Cogent Biosciences Inc. nowInsider Buying & Reliable Breakout Forecasts - Newser
Reversal indicators forming on Cogent Biosciences Inc. stockJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Is Cogent Biosciences Inc. forming a bullish divergencePortfolio Performance Report & High Conviction Buy Zone Alerts - sundaytimes.kr
Using AI based signals to follow Cogent Biosciences Inc.July 2025 Market Mood & Low Risk Investment Opportunities - Newser
Will Volume Confirm Reversal in Cogent Biosciences Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Cogent Biosciences Inc. Shows Support at Fibonacci LevelEarnings Miss & Free Growth Oriented Trading Recommendations - beatles.ru
Published on: 2025-08-28 19:10:32 - Newser
Levels Update: Is Cogent Biosciences Inc. in a bullish channelMarket Sentiment Summary & Reliable Price Breakout Signals - sundaytimes.kr
Will Cogent Biosciences Inc. see short term momentum2025 EndofYear Setup & Daily Growth Stock Investment Tips - Newser
Is Cogent Biosciences Inc. meeting your algorithmic filter criteriaQuarterly Portfolio Summary & AI Enhanced Execution Alerts - Newser
Will breakout in Cogent Biosciences Inc. lead to full recovery - Newser
Is Cogent Biosciences Inc. stock poised for growthInsider Selling & Technical Entry and Exit Tips - Newser
Cogent Biosciences Inc Stock (COGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):